Cargando…

Prognostic value of immunotherapy-induced organ inflammation assessed on (18)FDG PET in patients with metastatic non-small cell lung cancer

PURPOSE: We evaluated the prognostic value of immunotherapy-induced organ inflammation observed on (18)FDG PET in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs). METHODS: Data from patients with IIIB/IV NSCLC included in two different prospective t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Humbert, Olivier, Bauckneht, Matteo, Gal, Jocelyn, Paquet, Marie, Chardin, David, Rener, David, Schiazza, Aurelie, Genova, Carlo, Schiappa, Renaud, Zullo, Lodovica, Rossi, Giovanni, Martin, Nicolas, Hugonnet, Florent, Darcourt, Jacques, Morbelli, Silvia, Otto, Josiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399195/ https://www.ncbi.nlm.nih.gov/pubmed/35562529 http://dx.doi.org/10.1007/s00259-022-05788-8

Ejemplares similares

Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study
por: Chardin, David, et al.
Publicado: (2020)

Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT
por: Comte, Victor, et al.
Publicado: (2022)

Beyond Covid-19 vaccination-associated pitfalls on [(18)F]Fluorodeoxyglucose (FDG) PET: a case of a concomitant sarcoidosis
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence
por: Piva, Roberta, et al.
Publicado: (2017)

Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience
por: Monaco, Lavinia, et al.
Publicado: (2021)

Metabolic signature of hyposmia after mild COVID-19: An [18]F-FDG-pet study
por: Pardini, Matteo, et al.
Publicado: (2021)

Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
por: Bauckneht, Matteo, et al.
Publicado: (2021)

(18)F-FDG-PET correlates of aging and disease course in ALS as revealed by distinct PVC approaches
por: Ferraro, Pilar M., et al.
Publicado: (2022)

Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach
por: Miceli, Alberto, et al.
Publicado: (2021)

Pneumo-renal sarcoidosis revealed by F-18 FDG PET/CT
por: Lambert, Michel, et al.
Publicado: (2010)

2-[(18)F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study
por: Gay, Stefano, et al.
Publicado: (2022)

10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2022)

The Elusive Link Between Cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in Diabetes
por: Cossu, Vanessa, et al.
Publicado: (2020)

The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
por: Bauckneht, Matteo, et al.
Publicado: (2021)

A Score-Based Approach to (18)F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility
por: Bauckneht, Matteo, et al.
Publicado: (2017)

PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area
por: Verger, Antoine, et al.
Publicado: (2022)

Beyond the Prognostic Value of 2-[(18)F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management
por: Borea, Roberto, et al.
Publicado: (2022)

The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Imaging Correlates between Headache and Breast Cancer: An [(18)F]FDG PET Study
por: Antunovic, Lidija, et al.
Publicado: (2023)

COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome
por: Dietz, Matthieu, et al.
Publicado: (2020)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Survival analysis of patient groups defined by unsupervised machine learning clustering methods based on patient metabolomic data.
por: Bailleux, Caroline, et al.
Publicado: (2023)

Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study
por: Sollini, Martina, et al.
Publicado: (2021)

Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223
por: Bauckneht, Matteo, et al.
Publicado: (2019)

Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
por: Tanda, Enrica Teresa, et al.
Publicado: (2021)

Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting
por: Ferrarazzo, Giulia, et al.
Publicado: (2021)

False positive (18)FDG PET-CT results due to exogenous lipoid pneumonia secondary to oily drug inhalation: A case report
por: Chardin, David, et al.
Publicado: (2017)

Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments
por: Genova, Carlo, et al.
Publicado: (2022)

Dissociated Response in Metastatic Cancer: An Atypical Pattern Brought Into the Spotlight With Immunotherapy
por: Humbert, Olivier, et al.
Publicado: (2020)

SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients
por: Morassi, Mauro, et al.
Publicado: (2021)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
por: Bouwman, Femke, et al.
Publicado: (2018)

(18)F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
por: Albano, Domenico, et al.
Publicado: (2023)

G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells
por: Scussolini, Mara, et al.
Publicado: (2019)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
por: Gosset, Marie, et al.
Publicado: (2021)

High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
por: Marotte, Delphine, et al.
Publicado: (2022)

ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
por: Evangelista, Laura, et al.
Publicado: (2023)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5k5kea933ia37j3i55ceshlh5e